344 related articles for article (PubMed ID: 16142870)
21. Interleukin-10 promoter polymorphisms in giant cell arteritis.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Catanoso MG; Pattacini L; Salvarani C
Arthritis Rheum; 2006 Dec; 54(12):4011-7. PubMed ID: 17133531
[TBL] [Abstract][Full Text] [Related]
22. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
23. Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis.
Torres O; Palomino-Morales R; Vazquez-Rodriguez TR; Castañeda S; Morado IC; Miranda-Filloy JA; Ortego-Centeno N; Gonzalez-Alvaro I; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
J Rheumatol; 2010 Jan; 37(1):131-5. PubMed ID: 19918040
[TBL] [Abstract][Full Text] [Related]
24. Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes.
Enjuanes A; Benavente Y; Hernández-Rodríguez J; Queralt C; Yagüe J; Jares P; de Sanjosé S; Campo E; Cid MC
Rheumatology (Oxford); 2012 May; 51(5):841-51. PubMed ID: 22258388
[TBL] [Abstract][Full Text] [Related]
25. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
Amoli MM; Garcia-Porrua C; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2005 Jan; 32(1):74-6. PubMed ID: 15630728
[TBL] [Abstract][Full Text] [Related]
26. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis.
Gonzalez-Gay MA; Rueda B; Vilchez JR; Lopez-Nevot MA; Robledo G; Ruiz MP; Fernández O; Garcia-Porrua C; Gonzalez-Escribano MF; Martín J
Rheumatology (Oxford); 2007 Mar; 46(3):431-4. PubMed ID: 17003171
[TBL] [Abstract][Full Text] [Related]
27. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
Arthritis Rheum; 2004 Aug; 51(4):652-5. PubMed ID: 15334440
[TBL] [Abstract][Full Text] [Related]
28. Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis.
Rueda B; González-Gay MA; López-Nevot MA; García A; Fernández-Arquero M; Balsa A; Pablos JL; Pascual-Salcedo D; de la Concha EG; González-Escribano MF; Martín J
Hum Immunol; 2005 Aug; 66(8):864-8. PubMed ID: 16216669
[TBL] [Abstract][Full Text] [Related]
29. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.
Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Gómez-Vaquero C; Marí-Alfonso B; Miranda-Filloy JA; Narvaez J; Ortego-Centeno N; Vicente EF; Blanco R; Amigo-Diaz E; Fernández-Gutiérrez B; Martin J; González-Gay MA
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S12-6. PubMed ID: 21269573
[TBL] [Abstract][Full Text] [Related]
30. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis.
Salvarani C; Casali B; Farnetti E; Pipitone N; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Catanoso MG; Boiardi L
J Rheumatol; 2005 Nov; 32(11):2173-7. PubMed ID: 16265697
[TBL] [Abstract][Full Text] [Related]
32. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
[TBL] [Abstract][Full Text] [Related]
33. Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study.
Gonzalez-Gay MA; Rubiera G; Piñeiro A; Garcia-Porrua C; Pego-Reigosa R; Gonzalez-Juanatey C; Sanchez-Andrade A; Llorca J
J Rheumatol; 2005 Mar; 32(3):502-6. PubMed ID: 15742443
[TBL] [Abstract][Full Text] [Related]
34. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.
Carmona FD; Serrano A; Rodríguez-Rodríguez L; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Solans R; Sopeña B; Marí-Alfonso B; Unzurrunzaga A; Ortego-Centeno N; Blanco R; de Miguel E; Hidalgo-Conde A; Martín J; González-Gay MA
J Rheumatol; 2011 Dec; 38(12):2598-601. PubMed ID: 21965647
[TBL] [Abstract][Full Text] [Related]
35. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.
Lee SJ; Lee SY; Jeon HS; Park SH; Jang JS; Lee GY; Son JW; Kim CH; Lee WK; Kam S; Park RW; Park TI; Kang YM; Kim IS; Jung TH; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):571-5. PubMed ID: 15767331
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses.
Nagy B; Savli H; Molvarec A; Várkonyi T; Rigó B; Hupuczi P; Rigó J
Clin Chim Acta; 2008 Mar; 389(1-2):126-31. PubMed ID: 18167313
[TBL] [Abstract][Full Text] [Related]
38. Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis.
Carmona FD; Rodríguez-Rodríguez L; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Marí-Alfonso B; Unzurrunzaga A; Ríos-Fernández R; Blanco R; de Miguel E; Martín J; González-Gay MA
Hum Immunol; 2011 May; 72(5):458-61. PubMed ID: 21354457
[TBL] [Abstract][Full Text] [Related]
39. Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.
Rodríguez-Pla A; Beaty TH; Savino PJ; Eagle RC; Seo P; Soloski MJ
Arthritis Rheum; 2008 Jun; 58(6):1849-53. PubMed ID: 18512818
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.
Kang S; Zhao J; Liu Q; Zhou R; Wang N; Li Y
Environ Mol Mutagen; 2009 Jun; 50(5):361-6. PubMed ID: 19197986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
